{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T23:01:49Z","timestamp":1773961309206,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.nmd.2022.01.013","type":"journal-article","created":{"date-parts":[[2022,2,5]],"date-time":"2022-02-05T10:33:08Z","timestamp":1644057188000},"page":"230-235","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Early safety and tolerability profile of the BNT162b2 COVID-19 vaccine in myasthenia gravis"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4015-9783","authenticated-orcid":false,"given":"Itay","family":"Lotan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark A.","family":"Hellmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yitzhak","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7715-6706","authenticated-orcid":false,"given":"Hadas","family":"Stiebel-Kalish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Israel","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adi","family":"Wilf-Yarkoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.nmd.2022.01.013_bib0001","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1111\/febs.15375","article-title":"A guide to COVID-19: a global pandemic caused by the novel coronavirus SARS-CoV-2","volume":"287","author":"Atzrodt","year":"2020","journal-title":"Febs j"},{"issue":"4","key":"10.1016\/j.nmd.2022.01.013_bib0002","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000149390","article-title":"Coronaviridae","volume":"20","author":"Siddell","year":"1983","journal-title":"Intervirology"},{"issue":"1","key":"10.1016\/j.nmd.2022.01.013_bib0003","first-page":"157","article-title":"WHO declares COVID-19 a pandemic","volume":"91","author":"Cucinotta","year":"2020","journal-title":"Acta Biomed"},{"issue":"8","key":"10.1016\/j.nmd.2022.01.013_bib0004","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1001\/jama.2020.12839","article-title":"Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review","volume":"324","author":"Wiersinga","year":"2020","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.nmd.2022.01.013_bib0005","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s11481-020-09944-5","article-title":"The natural history, pathobiology, and clinical manifestations of SARS-CoV-2 infections","volume":"15","author":"Machhi","year":"2020","journal-title":"J Neuroimmune Pharmacol"},{"key":"10.1016\/j.nmd.2022.01.013_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173751","article-title":"COVID-19 vaccine: a recent update in pipeline vaccines, their design and development strategies","volume":"892","author":"Rawat","year":"2021","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"10.1016\/j.nmd.2022.01.013_bib0007","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1080\/21645515.2020.1804777","article-title":"SARS-CoV-2 vaccine candidates in rapid development","volume":"17","author":"Li","year":"2021","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.nmd.2022.01.013_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2020.198114","article-title":"COVID-19 vaccine: a comprehensive status report","volume":"288","author":"Kaur","year":"2020","journal-title":"Virus Res"},{"issue":"10262","key":"10.1016\/j.nmd.2022.01.013_bib0009","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/S0140-6736(20)32137-1","article-title":"SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates","volume":"396","author":"Poland","year":"2020","journal-title":"Lancet"},{"issue":"27","key":"10.1016\/j.nmd.2022.01.013_bib0010","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.nmd.2022.01.013_bib0011","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nmd.2022.01.013_bib0012","unstructured":"COVID-19 resource center 2021 [Available from: https:\/\/myasthenia.org\/MG-Community\/COVID-19-Resource-Center."},{"key":"10.1016\/j.nmd.2022.01.013_bib0013","unstructured":"Interim Clinical Considerations for Use of COVID-19 Vaccines Currently Authorized in the United States 2021 [Available from: https:\/\/www.cdc.gov\/vaccines\/covid-19\/info-by-product\/clinical-considerations.html#underlying-conditions."},{"issue":"27","key":"10.1016\/j.nmd.2022.01.013_bib0014","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nmd.2022.01.013_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"issue":"2","key":"10.1016\/j.nmd.2022.01.013_bib0016","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"issue":"6","key":"10.1016\/j.nmd.2022.01.013_bib0017","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s00415-018-8751-9","article-title":"Myasthenia gravis and infectious disease","volume":"265","author":"Gilhus","year":"2018","journal-title":"J Neurol"},{"issue":"3","key":"10.1016\/j.nmd.2022.01.013_bib0018","doi-asserted-by":"crossref","first-page":"e299","DOI":"10.1212\/WNL.0000000000008688","article-title":"Myasthenic crisis demanding mechanical ventilation: a multicenter analysis of 250 cases","volume":"94","author":"Neumann","year":"2020","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.nmd.2022.01.013_bib0019","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/mus.26918","article-title":"COVID-19 in patients with myasthenia gravis","volume":"62","author":"Anand","year":"2020","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2022.01.013_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2020.117053","article-title":"Description of 3 patients with myasthenia gravis and COVID-19","volume":"417","author":"Rein","year":"2020","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.nmd.2022.01.013_bib0021","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.3389\/fneur.2020.01053","article-title":"Myasthenia gravis and COVID-19: clinical characteristics and outcomes","volume":"11","author":"Camelo-Filho","year":"2020","journal-title":"Front Neurol."},{"issue":"22","key":"10.1016\/j.nmd.2022.01.013_bib0022","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1212\/WNL.0000000000009566","article-title":"COVID-19 and neuromuscular disorders","volume":"94","author":"Guidon","year":"2020","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.nmd.2022.01.013_bib0023","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/S1474-4422(20)30413-0","article-title":"COVID-19-associated risks and effects in myasthenia gravis (CARE-MG)","volume":"19","author":"Muppidi","year":"2020","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nmd.2022.01.013_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2020.116888","article-title":"Myasthenic crisis in COVID-19","volume":"414","author":"Delly","year":"2020","journal-title":"J Neurol Sci"},{"issue":"3","key":"10.1016\/j.nmd.2022.01.013_bib0025","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/mus.27179","article-title":"Doctor-Should I get the COVID-19 vaccine? Infection and immunization in individuals with neuromuscular disorders","volume":"63","author":"\u017divkovi\u0107","year":"2021","journal-title":"Muscle Nerve"},{"issue":"2","key":"10.1016\/j.nmd.2022.01.013_bib0026","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.vaccine.2018.11.045","article-title":"Causal relationship between immunological responses and adverse reactions following vaccination","volume":"37","author":"Nakayama","year":"2019","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.nmd.2022.01.013_bib0027","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1080\/22221751.2021.1891002","article-title":"Inflammation-related adverse reactions following vaccination potentially indicate a stronger immune response","volume":"10","author":"Zhuang","year":"2021","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.nmd.2022.01.013_bib0028","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jim.2018.08.005","article-title":"Aging and the immune system: an overview","volume":"463","author":"Sadighi Akha","year":"2018","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.nmd.2022.01.013_bib0029","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/978-981-13-3681-2_2","article-title":"The immune system and its dysregulation with aging","volume":"91","author":"M\u00fcller","year":"2019","journal-title":"Subcell Biochem"},{"issue":"3","key":"10.1016\/j.nmd.2022.01.013_bib0030","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taw012","article-title":"Comparative study of adverse events after yellow fever vaccination between elderly and non-elderly travellers: questionnaire survey in Japan over a 1-year period","volume":"23","author":"Tanizaki","year":"2016","journal-title":"J Travel Med"},{"issue":"15\u201316","key":"10.1016\/j.nmd.2022.01.013_bib0031","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1016\/S0264-410X(98)00467-8","article-title":"Reactogenicity in the elderly of nine commercial influenza vaccines: results from the Italian SVEVA study. Study for the evaluation of adverse events of influenza vaccination","volume":"17","author":"Spila-Alegiani","year":"1999","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.nmd.2022.01.013_bib0032","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/mus.22077","article-title":"Safety of influenza and H1N1 vaccinations in patients with myasthenia gravis, and patient compliance","volume":"43","author":"Auriel","year":"2011","journal-title":"Muscle Nerve"},{"issue":"4","key":"10.1016\/j.nmd.2022.01.013_bib0033","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3988\/jcn.2017.13.4.325","article-title":"The impacts of influenza infection and vaccination on exacerbation of myasthenia gravis","volume":"13","author":"Seok","year":"2017","journal-title":"J Clin Neurol"},{"issue":"46","key":"10.1016\/j.nmd.2022.01.013_bib0034","doi-asserted-by":"crossref","first-page":"6290","DOI":"10.1016\/j.vaccine.2017.09.078","article-title":"A prospective, placebo controlled study on the humoral immune response to and safety of tetanus revaccination in myasthenia gravis","volume":"35","author":"Strijbos","year":"2017","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.nmd.2022.01.013_bib0035","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.vaccine.2019.01.007","article-title":"A prospective, double-blind, randomized, placebo-controlled study on the efficacy and safety of influenza vaccination in myasthenia gravis","volume":"37","author":"Strijbos","year":"2019","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.nmd.2022.01.013_bib0036","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/mus.21440","article-title":"Safety of influenza vaccination in patients with myasthenia gravis: a population-based study","volume":"40","author":"Zinman","year":"2009","journal-title":"Muscle Nerve"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096089662200030X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S096089662200030X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:11:58Z","timestamp":1760775118000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S096089662200030X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S096089662200030X"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2022.01.013","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early safety and tolerability profile of the BNT162b2 COVID-19 vaccine in myasthenia gravis","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2022.01.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}